Background Chronic pain is common in adults, and often has a detrimental impact upon
physical ability, well‐being, and quality of life. Previous reviews have shown that certain …

Duloxetine is a serotonin-norepinephrine reuptake inhibitor approved for the treatment of
patients affected by major depressive disorder (MDD), generalized anxiety disorder (GAD) …

PURPOSE To update the ASCO guideline on the recommended prevention and treatment
approaches in the management of chemotherapy-induced peripheral neuropathy (CIPN) in …

Chemotherapy-induced peripheral neurotoxicity (CIPN) is a major dose-limiting side effect of
many anti-cancer agents, including taxanes, platinums, vinca alkaloids, proteasome …

Oxaliplatin-based chemotherapy is a standard treatment approach for colorectal cancer
(CRC). However, oxaliplatin-induced peripheral neurotoxicity (OIPN) is a severe dose …

Neuropathic pain is a challenging chronic pain condition. Limited knowledge exists
regarding the relative effectiveness of pharmacological treatments, and differences in trial …

Background The prognosis of pancreatic cancer (PC) has been improved by new
chemotherapy regimens (combination of 5-fluorouracil, oxaliplatin, irinotecan, and …

Summary of the Clinical Problem Chemotherapy-induced peripheral neuropathy (CIPN) is a
particularly challenging pain syndrome that typically occurs in patients with cancer who have …

Purpose The aim in this review was to explore recent advances in chemotherapy-induced
peripheral neuropathy (CIPN) management interventions and to identify the implications for …

Introduction Duloxetine has previously been reported to be promising in the setting of
chemotherapy-induced peripheral neuropathy (CIPN). The aim of this study was to conduct …